Basit öğe kaydını göster

dc.contributor.authorÇirak, Selen
dc.contributor.authorTÜZÜN, Erdem
dc.contributor.authorKoral, Gizem
dc.contributor.authorGünaydin, Sefer
dc.contributor.authorBaştan, Birgül
dc.contributor.authorBayar, Muhammet Duran
dc.contributor.authorŞişman, Aysel Büşra
dc.date.accessioned2023-02-21T08:22:50Z
dc.date.available2023-02-21T08:22:50Z
dc.date.issued2022
dc.identifier.citationBayar M. D., Şişman A. B., Koral G., Çirak S., TÜZÜN E., Günaydin S., Baştan B., "INCREASED SERUM CITRULLINATED HISTONE H3 LEVELS IN COVID-19 PATIENTS WITH ACUTE ISCHEMIC STROKE AKUT ISCHAEMIÁS STROKE-BAN SZENVEDÔ COVID-19-BETEGEK KÖRÉBEN MEGNÔ A SZÉRUM CITRULLINÁLT HISZTON H3-SZINTJE", Ideggyogyaszati Szemle, cilt.75, sa.5-6, ss.191-198, 2022
dc.identifier.issn0019-1442
dc.identifier.othervv_1032021
dc.identifier.otherav_199388c5-c92c-46a9-9081-20a6526c8025
dc.identifier.urihttp://hdl.handle.net/20.500.12627/186605
dc.identifier.urihttps://doi.org/10.18071/isz.75.0191
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85132778104&origin=inward
dc.description.abstract© 2022 Ifjusagi Lap-es Konyvkiado Vallalat. All rights reserved.Background and purpose – Prevalence of acute ischemic stroke (AIS) is increased in patients with coronavirus disease 2019 (COVID-19). A proposed hypothesis is increased virus-induced propensity to hypercoagulation resulting in arterial thrombosis. Our aim was to provide evidence regarding the involvement of neutrophil extracellular trap (NET) formation (NETosis) in COVID-19 related AIS. Methods – Twenty-six consecutively enrolled COVID-19+ pneumonia patients with AIS, 32 COVID-19+ pneumonia patients without AIS and 24 AIS patients without COVID-19 infection were included to the study. Clinical characteristics of recruited patients were collected. Serum levels of citrullinated histone H3 (H3Cit; a factor of NETosis), IL-8 and C5a (mediators associated with NETosis) were measured by ELISA (enzyme-linked immunosorbent assay). Results – H3Cit levels were significantly higher in COVID-19+ AIS patients, whereas all study groups showed comparable IL-8 and C5a levels. There were no significant differences among etiological subgroups of AIS patients with or without COVID-19. AIS patients with COVID-19 showed relatively increased white blood cell, lymphocyte, neutrophil, D-dimer, C-reactive protein and procalcitonin levels than control groups. H3Cit levels did not correlate with clinical/prognostic features and inflammation parameters. H3Cit and IL-8 levels were correlated in COVID-19 patients without stroke but not in COVID-19 positive or negative AIS patients. Conclusion – Increased levels of inflammation parameters and H3Cit in COVID-19 related AIS suggest that NETosis may cause susceptibility to arterial thrombosis. However, H3Cit levels do not correlate with clinical severity measures and inflammation parameters diminishing the prognostic biomarker value of NETosis factors. Moreover, the link between IL-8 and NETosis appears to be abolished in AIS.
dc.language.isoeng
dc.subjectNeurology (clinical)
dc.subjectHealth Sciences
dc.subjectDahili Tıp Bilimleri
dc.subjectNeurology
dc.subjectLife Sciences
dc.subjectNöroloji
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp
dc.subjectKLİNİK NÖROLOJİ
dc.subjectKlinik Tıp (MED)
dc.titleINCREASED SERUM CITRULLINATED HISTONE H3 LEVELS IN COVID-19 PATIENTS WITH ACUTE ISCHEMIC STROKE AKUT ISCHAEMIÁS STROKE-BAN SZENVEDÔ COVID-19-BETEGEK KÖRÉBEN MEGNÔ A SZÉRUM CITRULLINÁLT HISZTON H3-SZINTJE
dc.typeMakale
dc.relation.journalIdeggyogyaszati Szemle
dc.contributor.departmentUniversity of Health Sciences , ,
dc.identifier.volume75
dc.identifier.issue5-6
dc.identifier.startpage191
dc.identifier.endpage198
dc.contributor.firstauthorID3434265


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster